Aurinia Pharma and partner Otsuka have secured approval in the EU for Lupkynis, billed as the first oral treatment for active nephritis in patients with the autoimmune disease systemic lupus ...

The Lupus Foundation of America says the disease affects an estimated 1.5 million Americans, 90% of them being women. Major lupus research projects are taking place in Utica. The institute is ...